Statistics for Assertio Therapeutics (id:5381 ASRT)

Valuation metrics

Market cap

81.23M

Enterprise value

37.83M

Trailing P/E (ttm)

1.20

Forward P/E

-14.20

PEG ratio

-14.20

Price/Sales (ttm)

0.65

Price/Book (mrq)

0.62

Enterprise Value/Revenue

0.30

Enterprise Value/EBITDA

2.30

Overview

Shares outstanding

95.34M

Float

83.70M

Shares short

6.20M

% Held by insiders

0.02%

% Held by institutions

0.38%

Average volume (10 days)

1.11M

Average volume (90 days)

Price summary

52-Week low

0.73

52-Week high

1.80

52-Week change

-30.53%

Beta

0.84

50-Day moving average

1.14

200-Day moving average

1.09

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

May 18th, 2021

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-54.46%

Operating margin

-9.41%

Operational effectiveness

Return on assets

-1.44%

Return on equity

-42.36%

Income statement

Revenue (ttm)

1.32

Revenue per share (ttm)

1.32

Quarterly revenue growth (yoy)

Gross profit (ttm)

125.05M

EBITDA

36.68M

Net income to common (ttm)

-68,489,000.00

Diluted EPS (ttm)

-4.85

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

88.58M

Total cash per share (mrq)

0.94

Total debt (mrq)

38.84M

Total Debt/Equity (mrq)

29.76

Current ratio (mrq)

201.10%

Book value per share (mrq)

1.38

Cash flow

Cash flow statement

20.57M

Levered free cash flow (LFCF)

19.03M